Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VULVIE: Laser +/- Clobetasol for Vulvar Lichen Sclerosus
NCT04951206Phase 4Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Mar 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clobetasol in vulvar lichen sclerosus (LS), sponsored by MedStar Health Research Institute. Started Mar 2022; status: completed.
02
Drugs
clobetasol
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT04951206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951206.